http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1974746-A2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6fbd0ac6f8b381ef42f7d1a6eed1dba |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
filingDate | 2008-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f70d73647dadd5e0e0258f8289b700c5 |
publicationDate | 2008-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-1974746-A2 |
titleOfInvention | Use of an adjuvanted allergy vaccine formulation for parenteral administration |
abstract | The present invention relates to the use of a seasonal allergen composition for the manufacture of a vaccine formulation for preventing or treating allergy to the allergen composition in a subject by parenteral administration, wherein the vaccine formulation is administered in a dosage regimen comprising an up-dosing phase, wherein the up-dosing phase partly or wholly overlaps with the allergen season of the allergen composition. |
priorityDate | 2007-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 142.